UPDATE 1-Gilead says panel rejects Roche's claims on hep C drug

(Adds analyst comment, background; updates share movement)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.